Clinical Trials, Availability & Alternatives
Retatrutide is investigational and not yet FDA-approved.
Short answer: No. Retatrutide is not commercially available anywhere in the world as of January 2026.
The only way to access retatrutide right now is through a clinical trial. Here's what you need to know:
| Trial | Phase | Focus | Status |
|---|---|---|---|
| TRIUMPH-1 | Phase 3 | Obesity | Enrolling |
| TRIUMPH-2 | Phase 3 | Obesity | Enrolling |
| TRIUMPH-3 | Phase 3 | Obesity | Enrolling |
| TRIUMPH-4 | Phase 3 | Obesity + Diabetes | Enrolling |
While waiting for retatrutide, several highly effective GLP-1 medications are available today:
Tirzepatide is a dual GLP-1/GIP agonist—it targets two of the three receptors that retatrutide does.
Compounded Tirzepatide
$297/month
Check EligibilityCompounded Semaglutide
$199/month
Check EligibilityBrand Options
$349+/month
Check Eligibility| If you want... | Choose... | Why |
|---|---|---|
| Maximum weight loss now | Tirzepatide | Closest results to retatrutide |
| Lowest cost | Compounded semaglutide | $199/month available |
| Most safety data | Brand Wegovy | Longest track record |
| Insurance coverage | Mounjaro (for diabetes) | Often covered for T2D |
You may see websites selling "retatrutide peptide" or "research grade retatrutide." Do not buy these products.
Don't wait for a hypothetical future drug. Tirzepatide is available today and produces similar results.
Compare Providers →Document your weight loss journey. This helps establish a baseline and shows your doctor what's working.
Sign up above for retatrutide updates. When it becomes available, you'll be among the first to know.